Comparison of analytical methods for the evaluation of antibody responses against epitopes of polymorphic protein antigens

Journal of Immunological Methods

Volumn 276, Issue 1-2, 2003, Pages 19-31

  Helg, A ^a   Mueller, M S ^a   Joss, A ^a   Poltl Frank F ^a   Stuart, F ^b   Robinson, J A ^b   Pluschke, G ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Affinity constant determination; Antibody binding; Antigenic polymorphism; Malaria

Indexed keywords

ANTIGEN; EPITOPE; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; MONOCLONAL ANTIBODY;

ALLELISM; AMINO ACID SEQUENCE; ANALYTIC METHOD; ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; CALORIMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; TITRIMETRY; WESTERN BLOTTING;

PLASMODIUM FALCIPARUM;

EID: 0037407510     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(03)00075-9     Document Type: Article

References (32)

1. Blackman M.J., Heidrich H.G., Donachie S., McBride J.S., Holder A.A. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172:1990;379.
2. Chang S.P., Case S.E., Gosnell W.L., Hashimoto A., Kramer K.J., Tam L.Q., Hashiro C.Q., Nikaido C.M., Gibson H.L., Lee-Ng C.T., Barr P.J., Yokota B.T., Hut G.S. Recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:1996;253.
3. Cheung A., Leban J., Shaw A.R., Merkli B., Stocker J., Chizzolini C., Sander C., Perrin L.H. Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies. Proc. Natl. Acad. Sci. U. S. A. 83:1986;8328.
4. Daubenberger C.A., Nickel B., Ciatto C., Grütter M.G., Pöltl-Frank F., Rossi L., Siegler U., Robinson J., Kashala O., Patarroyo M.E., Pluschke G. Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein-1 displaying dimorphic amino acid polymorphism are highly constrained. Eur. J. Immunol. 32:2002;3667.
5. Egan A.F., Blackman M.J., Kaslow D.C. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys. Infect. Immun. 68:2000;1418.
6. Engers H.D., Godal T. Malaria vaccine development: current status. Parasitol. Today. 14:1998;56.
7. Etlinger H., Caspers P., Matile H., Schönfeld H., Stüber D., Tacacs B. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect. Immun. 59(10):1991;3498.
8. Hall R., Hyde J.E., Goman M., Simmons D.L., Hope I.A., Mackay M., Scaife J., Merkli B., Richle R., Stocker J. Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature. 311:1984;379-382.
9. Holder A.A., Freeman R.R. The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor. J. Exp. Med. 160:1984;624-629.
10. Hui G.S., Siddiqui W.A. Serum from Pf195 protected Aotus monkeys inhibit Plasmodium falciparum growth in vitro. Exp. Parasitol. 64:1987;519-522.
11. Jiang G., Daubenberger C., Huber W., Matile H., Tanner M., Pluschke G. Sequence diversity of the merozoite surface protein 1 of Plasmodium falciparum in clinical isolates from the Kilombero District, Tanzania. Acta Trop. 74(1):2000;51.
12. Kumar S., Collins W., Egan A., Yadava A., Garraud O., Blackman M.J., Guevara Patino J.A., Diggs C., Kaslow D.C. Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1. Infect. Immun. 68(4):2000;2215.
13. Lefranc M.P. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 29(1):2001;207.
14. Locher C.P., Tam L.Q., Chang S.P., McBride J.S., Siddiqui W.A. Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro. Exp. Parasitol. 84(1):1996;74.
15. Martinez C., Lefranc M.P. The mouse (Mus musculus) immunoglobulin kappa variable (IGKV) genes and joining (IGKJ) segments. Exp. Clin. Immunogenet. 15(3):1998;184.
16. Matile H., Pink J.R.L. Plasmodium falciparum malaria parasite cultures and their use in immunology. Lefkovits I., Benvenuto P. Immunological Methods. 1990;221-234 Academic Press, San Diego.
17. Mattes M.J. Binding parameters of antibodies reacting with multivalent antigens: functional affinity or pseudo-affinity. J. Immunol. Methods. 202:1997;97.
18. Miller L.H., Roberts T., Shahabuddin M., McCutchan T.F. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol. Biochem. Parasitol. 59:1993;1.
19. Neri D., Montigiani S., Kirkham P.M. Biophysical methods for the determination of antibody-antigen affinities. Tibtech. 14:1996;465.
20. Nygren H., Stenberg M. Immunochemistry at interfaces. J. Immunol. Methods. 66:1989;321.
21. Nygren H., Werthen M., Stenberg M. Kinetics of antibody binding to solid-phase-immobilised antigen. Effect of diffusion rate limitation and steric interaction. J. Immunol. Methods. 101(1):1987;63.
22. Patarroyo M.E., Romero P., Torres M.L., Clavijo P., Moreno A., Martinez A., Rodriguez R., Guzman F., Cabezas E. Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature. 328:1987;629.
23. Patarroyo M.E., Amador R., Clavijo P., Moreno A., Guzman F., Romero P., Tascon R., Franco A., Murillo L.A., Ponton G., Trujillo G. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature. 332:1988;158.
24. Pierce M.M., Raman C.S., Nall B.T. Isothermal titration calorimetry of protein-protein interactions. Methods. 19(2):1999;213-221. (Oct.).
25. Pluschke G., Joss A., Marfurt J., Daubenberger C., Kashala O., Zwickl M., Stief A., Sansig G., Schlapfer B., Linkert S., van der Putten H., Hardman N., Schröder M. Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin Cgamma1 heavy of Ckappa light chain gene segments. J. Immunol. Methods. 215(1-2):1998;27-37.
26. Richie T.L., Saul A. Progress and challenges for malaria vaccines. Nature. 415:2002;694-701.
27. Savoca R., Schwab C., Bosshard H.R. Epitope mapping employing immobilized synthetic peptides. How specific is the reactivity of these peptides wit the antiserum raised against the parent protein? J. Immunol. Methods. 141:1991;245.
28. Shi Y.P., Hasnain S.E., Sacci J.B., Holloway B.P., Fujioka H., Kumar N., Wohlhueter R., Hoffman S.L., Collins W.E., Lal A.A. Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. Proc. Natl. Acad. Sci. U. S. A. 96:1999;1615-1620.
29. Siddiqui W.A., Tam L.Q., Kramer K.J., Hui G.S., Case S.E., Yamaga K.M., Chang S.P., Chan E.B., Kann S.C. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. U. S. A. 84(9):1987;3014.
30. Stenberg M., Nygren H. Kinetics of antigen-antibody reactions at solid-liquid interfaces. J. Immunol. Methods. 113(1):1989;3.
31. Underwood P.A. Problems and pitfalls with measurement of antibody affinity using solid phase binding in the ELISA. J. Immunol. Methods. 164:1993;119.
32. Wiseman T., Williston S., Brandt J.F., Lung-Nan L. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal. Biochem. 179:1989;131.